KeyCorp Lowers UnitedHealth Group (NYSE:UNH) Price Target to $400.00

UnitedHealth Group (NYSE:UNH) had its price target decreased by equities researchers at KeyCorp from $450.00 to $400.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. KeyCorp’s price objective would indicate a potential upside of 31.22% from the company’s current price.

A number of other research analysts also recently commented on the company. Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Robert W. Baird reduced their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Finally, Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $439.70.

UnitedHealth Group Trading Up 2.2%

Shares of UnitedHealth Group stock opened at $304.83 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a fifty day simple moving average of $430.87 and a 200-day simple moving average of $492.75. The stock has a market cap of $276.52 billion, a price-to-earnings ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. On average, equities analysts forecast that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company’s stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of UNH. Financial Management Professionals Inc. boosted its position in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after buying an additional 17 shares during the period. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the last quarter. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after acquiring an additional 20 shares during the last quarter. 44 Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.